Analyzing the Relationship Between Speed Propofol is Given and Low Blood Pressure
Analyzing the Relationship Between Rate of Induction and Perioperative Hypotension Using Propofol
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Contact
Study Contact
- Name: Tanaya Sparkle, MD
- Phone Number: 419-383-3556
- Email: tanaya.sparkle@utoledo.edu
Study Contact Backup
- Name: Kristi Baker, RN
- Phone Number: 419-383-6223
- Email: kristi.baker@utoledo.edu
Study Locations
-
-
Ohio
-
Toledo, Ohio, United States, 43614
- The University of Toledo Medical Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- any patient from 18 till 80 years of age
- patient undergoing non-cardiac elective surgery
- duration of the surgery longer than one hour
- native/fluent English speaker
- patients whose staff anesthesiologist planned to use Propofol as a primary anesthetic for induction
Exclusion Criteria:
- any patient admitted for non-elective surgery
- any patient undergoing cardiac surgery
- any patient under 18 years of age
- any patient older than 80 years of age
- any patient with history of severe heart disease (CHF with significant limitations of activity due to sever symptoms, prior heart surgery, atrial fibrillation, etc.)
- any patient with pre-operative hemodynamic instability (e.g. sepsis, chronic kidney disease, liver cirrhosis) who requires constant or intermittent administration of vasoactive or inotropic medication to support vital signs (BP)
- any patient on vasoactive or inotrop medications in early pre-operative period (within 24 hours prior to the surgery)
- any patient who does not speak English or not fluently
- any patient with cognitive impairment or mentally incapacitation
- any pregnant or breastfeeding females
- any patient whose staff anesthesiologist planned to use a primary anesthetic other than Propofol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Group A- propofol given at FDA approved administration speed
|
|
|
Experimental: Group B- propofol given over 120 seconds
|
Propofol will be slowly administered over 120 seconds by anesthesia provider
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients Administered Propofol at a Slower Rate of Infusion Will Have Lower Incidence of Post Induction Hypotension Than Patients Administered Propofol at FDA Approved Rate.
Time Frame: induction to 1 hour post induction
|
We will collect the patient's blood pressure intra-operatively every 5 minutes starting on induction up to one hour after induction and compare.
|
induction to 1 hour post induction
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients Administered Propofol at a Slower Rate Will Have Less Complications During the Early Post-op Period Than Patients Administered Propofol at FDA Approved Rate.
Time Frame: immediate post-op to 30 days post operatively
|
We will collect the patient's blood pressure post-operatively and length of hospital stay and compare.
|
immediate post-op to 30 days post operatively
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Scott Pappada, PhD, University of Toledo
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Propofol study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.